BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MediciNova, Inc. 

4350 La Jolla Village Drive, Suite 950

San Diego  California  92122  U.S.A.
Phone: 858-373-1500 Fax: 858-373-7000


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Liver Disorders 12/10/2014 7:00:41 AM
CDC Supports Recruitment For MediciNova, Inc.'s Clinical Trial Of MN-166 (Ibudilast) In ALS 10/24/2014 7:26:44 AM
MediciNova, Inc. Announces FDA Granted Orphan Drug Designation To MN-001 (Tipelukast) For Idiopathic Pulmonary Fibrosis (IPF) 10/23/2014 7:20:32 AM
MediciNova, Inc. Receives Feedback From FDA Regarding Study Protocol For Phase 2 Trial Of MN-001 (Tipelukast) In NASH 10/9/2014 7:35:14 AM
MediciNova, Inc.'s MN-001 (Tipelukast) NASH Abstract Selected For Late-Breaking Session At The 65th Annual American Association for Study of Liver Diseases Meeting In Boston 10/7/2014 7:26:14 AM
Overview Of MediciNova, Inc.''s Clinical Trial Of MN-166 (Ibudilast) In ALS To Be Presented At The 13th Annual NEALS Meeting 9/30/2014 7:27:58 AM
MediciNova, Inc. Provides Update On Phase 2b Trial Of MN-166 (Ibudilast) In Progressive MS 9/24/2014 7:21:14 AM
MediciNova, Inc. Announces New NIDA Grant For MN-166 (Ibudilast) In Opioid Dependence 9/8/2014 7:42:08 AM
MediciNova, Inc. To Present Data On MN-001 (Tipelukast) For The Treatment Of Idiopathic Pulmonary Fibrosis (IPF) During The 18th International Colloquium On Lung And Airway Fibrosis (ICLAF) 9/2/2014 7:55:20 AM
MediciNova, Inc. To Initiate Clinical Trial Of MN-166 (Ibudilast) In ALS 8/26/2014 7:16:24 AM
12345678910...